Kanglexin is a novel oral anthraquinone that inhibits NLRP3 inflammasome-driven pyroptosis, providing cardioprotection. It promotes angiogenesis via FGFR1/ERK signaling for diabetic wound healing and exhibits anti-atherosclerotic potential by lowering lipids and inhibiting vascular smooth muscle cell dedifferentiation in research models.
Molekulargewicht:
398.36
CAS Nummer:
[2228847-12-7]
Formel:
C21H18O8
Target-Kategorie:
Pyroptosis,FGFR,AMPK,ERK,NOD-like Receptor (NLR)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten